Highlights from the 82<sup>nd</sup> ADA Scientific Sessions and the 58<sup>th</sup> EASD Meeting on Diabetic Neuropathy-Reference-Cited by-同舟云学术

Highlights from the 82^nd ADA Scientific Sessions and the 58^th EASD Meeting on Diabetic Neuropathy

Published:2023-05-22 Issue: Volume: Page:153473462311775
ISSN:1534-7346
Container-title:The International Journal of Lower Extremity Wounds
language:en
Short-container-title:The International Journal of Lower Extremity Wounds

Author:

Tentolouris Anastasios¹^ORCID,Eleftheriadou Ioanna¹,Tentolouris Nikolaos¹,Papanas Nikolaos²^ORCID

Affiliation:

1. First Department of Propaedeutic Internal Medicine and Diabetes Center, School of Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece

2. Diabetes Centre-Diabetic Foot Clinic, Democritus University of Thrace, Alexandroupolis, Greece

Abstract

Diabetic neuropathy is one of the commonest diabetic complications. It affects 30-50% of people with diabetes mellitus (DM) and may cause severe pain and foot ulcers. Distal symmetric polyneuropathy and diabetic autonomic neuropathy are the main manifestations of diabetic neuropathy. The American Diabetes Association's (ADA) 82nd Scientific Sessions took place in June 2022 in New Orleans, Louisiana, and the 58th European Association for the Study of Diabetes (EASD) Annual Meeting was held in September 2022 in Stockholm, Sweden. Herein, we describe interesting studies in the field of diabetic neuropathy presented in these two meetings.

Publisher

SAGE Publications

Subject

General Medicine,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/15347346231177569

Reference27 articles.

1. Diabetic Neuropathy: A Position Statement by the American Diabetes Association

2. Diabetic Autonomic Neuropathy

3. Diabetes Prevention Program (DPP). Accessed: April 4, 2023. https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes-prevention-program-dpp.

4. The Defective Glucagon Response From Transplanted Intrahepatic Pancreatic Islets During Hypoglycemia Is Transplantation Site–Determined